Pharmaceuticals, Biotechnology and Life Sciences
FDA has announced updates to three final guidances, including Form FDA 3926 and its instructions, to simplify Institutional Review Board (IRB)…
Data presented by Tetraphase Pharmaceuticals at IDWeek confirmed that the timing of oral dosing relative to meals drove the lower…
The Medicines Patent Pool (MPP) today announced a licence with Gilead Sciences for bictegravir (BIC), now under review in the United…
OptiBiotix Health has kicked off with its SlimBiome and LPLDL products at Supply Side West in Las Vegas, in late September 2017.
Evgen Pharma got the grant of the first European patent for its lead product, SFX-01.
ImmuPharma has completed a sharing agreement with Lanstead Capital from February 2016, for supporting of ImmuPharma’s pivotal Phase III clinical trial…
The U.S. Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for Allergan’s Avycaz (ceftazidime and avibactam) for priority review.
Sanofi has appointed Stefan Oelrich as Executive Vice President Diabetes & Cardiovascular (DCV), effectively immediately.
Alcon, a division of Novartis, will introduce Clareon, the intraocular lens (IOL) with the most advanced optic material available in an automated, disposable, pre-loaded delivery system, at the XXXV European Society of Cataract & Refractive Surgeons (ESCRS) congress taking place October 7 – 11 in Lisbon, Portugal.
Eli Lilly has made certain leadership changes, promoting several experienced Lilly leaders to executive roles, effective in 2018.